ABBV vs QGEN: Which Is the Better Dividend Stock?
As of July 2026, ABBV (AbbVie Inc.) screens as the stronger dividend stock, winning 5 of 7 head-to-head metrics. ABBV offers the higher yield at 2.65%, ABBV has the higher dividend-safety score, and QGEN trades at the larger discount to fair value (+25%).
| Metric | ABBV | QGEN |
|---|---|---|
| Forward yield | 2.65% | 0.87% |
| Annual dividend | $6.92 | $0.35 |
| Payout ratio | 326% | 13% |
| Years of growth | 12 yr | 0 yr |
| 5-yr dividend growth | 6.8% | — |
| 5-yr total return | 124% | -26% |
| Dividend safety score | 78 (B) | 57 (C) |
| Fair value estimate | $275.48 | $50.05 |
| Upside to fair value | +6% | +25% |
| Frequency | quarterly | annual |
| Market cap | $461.3B | $8.3B |
| P/E ratio | 128.0 | 20.5 |
Higher yield
ABBV
2.65%
Safer dividend
ABBV
Grade B
Faster growth
ABBV
6.8%
Better value
QGEN
+25% upside
ABBV vs QGEN — FAQ
Related comparisons
See more dividend stock comparisons · data refreshes daily · for informational purposes only, not investment advice.